New perspectives on Biotech capital formation

Published May 28, 2020 | 10 min read

RBC Capital Markets’ Vince Lozada and Tim Papp, both Managing Directors focused on biotechnology investment banking, provide perspectives on capital formation trends in the biotechnology sector.

BiotechnologyCOVID-19CoronavirusHealthcare